The present invention relates to novel formulations comprising lipoic acid andhyaluronic acid and/or the derivatives thereof for use in the repair ofchronic ulcers, the regeneration of damaged skin, the prevention of skin agingand, when administered by the systemic route, to treat peripheral neuropathiesand intoxications by chemical and/or biological agents.